Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

Clinical trial NCT05066412 · RECRUITING

Trial details

NCT number: NCT05066412
Sponsor: University Hospital, Geneva
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy Haplo-identical Stem Cell Transplantation

Start date: 2024-11-26
Primary completion: 2026-06-02
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.